Get the Stockscreener App
2.35
0.86%
0.02
After Hours:
2.66
0.31
+13.19%
Gt Biopharma Inc Stock (GTBP) Forecast
The Gt Biopharma Inc (GTBP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.057, representing a -55.02% decrease from the current price of $2.35. The highest analyst price target is $1.4612, and the lowest is $0.6528.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GTBP Price Target
Average 0.9922
(-57.78% Downside)
Is Gt Biopharma Inc (GTBP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.80 | Neutral |
| STOCH(9,6) | 51.93 | Neutral |
| STOCHRSI(14) | 58.53 | Neutral |
| MACD(12,26) | -0.00486 | Sell |
| ADX(14) | 25.91 | Sell |
| William %R | -43.24 | Neutral |
| CCI(14) | -56.38 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.337
Buy
|
2.3466
Buy
|
| MA20 |
2.3945
Sell
|
2.3547
Sell
|
| MA50 |
2.2902
Buy
|
2.374
Sell
|
| MA100 |
2.5276
Sell
|
2.4619
Sell
|
| MA200 |
2.4987
Sell
|
2.9057
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, GTBP could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 9 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on GTBP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.8 indicates that GTBP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 51.93 indicates that GTBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 58.53 indicates that GTBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.91 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -56.38 indicates that GTBP is still oversold but not to an extreme extent.
Long-term GTBP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Gt Biopharma Inc financial reports and earnings history, Gt Biopharma Inc (GTBP) stock could reach $2.028 by 2030, $5.6908 by 2040 and $4.4073 by 2050. See the projected annual prices until 2050 of the Gt Biopharma Inc stock below:
- Gt Biopharma Inc (GTBP) is expected to reach an average price of $0.4702 in 2035, with a high prediction of $0.9097 and a low estimate of $0.0176. This indicates an $-79.99% rise from the last recorded price of $2.35.
- Gt Biopharma Inc (GTBP) stock is projected to chart a bullish course in 2040, with an average price target of $5.8488, representing an $148.88% surge from its current level. The forecast ranges from a conservative $5.8798 to a sky-high $5.6908.
- Our analysts predict Gt Biopharma Inc (GTBP) to jump 268.69% by 2045, soaring from $8.6712 to an average price of $8.6643, potentially reaching $8.6356. While $8.6712 is the low estimate, the potential upside is significant.
- Gt Biopharma Inc (GTBP) stock is expected to climb by 2050, reaching an average of $3.5964, a $53.04% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.4073 and $4.15, respectively, highlighting the market's uncertainty.
Gt Biopharma Inc Stock (GTBP) Year by Year Forecast
Gt Biopharma Inc Stock (GTBP) Price Forecast for 2025
Gt Biopharma Inc Stock (GTBP) is expected to reach an average price of $2.9004 in 2025, with a high prediction of $5.6082 and a low estimate of $0.1927. This indicates an +23.42% rise from the last recorded price of $2.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.8512 | $0.6528 | $1.4612 | -63.78% |
| June, 2025 | $1.388 | $0.6954 | $1.9396 | -40.93% |
| July, 2025 | $1.1091 | $0.8307 | $1.6164 | -52.81% |
| August, 2025 | $0.5559 | $0.5017 | $1.2183 | -76.35% |
| September, 2025 | $0.9327 | $0.1927 | $0.9777 | -60.31% |
| October, 2025 | $1.2037 | $0.6469 | $1.3837 | -48.78% |
| November, 2025 | $1.2505 | $1.0563 | $1.5779 | -46.79% |
| December, 2025 | $1.0715 | $0.7314 | $1.4131 | -54.40% |
Gt Biopharma Inc Stock (GTBP) Price Forecast for 2026
The predicted value for Gt Biopharma Inc (GTBP) in 2026 is set at an average of $0.6303. Estimates vary from a peak of $1.2158 to a trough of $0.0448, indicating an -73.18% surge from the present price of $2.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.8784 | $0.6242 | $1.2158 | -62.62% |
| February, 2026 | $0.1152 | $0.0448 | $1.0826 | -95.10% |
| March, 2026 | $0.312 | $0.0536 | $0.332 | -86.72% |
| April, 2026 | $0.223 | $0.1428 | $0.6846 | -90.51% |
| May, 2026 | $0.2902 | $0.0786 | $0.2356 | -87.65% |
| June, 2026 | $0.6032 | $0.576 | $0.4933 | -74.33% |
| July, 2026 | $0.7023 | $0.6691 | $0.6065 | -70.11% |
| August, 2026 | $0.8155 | $0.8469 | $0.8066 | -65.30% |
| September, 2026 | $1.0545 | $1.0024 | $0.9145 | -55.13% |
| October, 2026 | $1.1978 | $1.1202 | $1.0908 | -49.03% |
| November, 2026 | $1.2557 | $1.215 | $1.1909 | -46.57% |
| December, 2026 | $1.1478 | $1.1697 | $1.177 | -51.16% |
Gt Biopharma Inc Stock (GTBP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Gt Biopharma Inc (GTBP) is $2.2279, with a high forecast of $4.4557 and a low forecast of $0.00. This indicates an -5.20% decrease from the last price of $2.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.1608 | $1.1672 | $1.1157 | -50.60% |
| February, 2027 | $1.1646 | $1.1651 | $1.1548 | -50.44% |
| March, 2027 | $1.1252 | $1.1444 | $1.149 | -52.12% |
| April, 2027 | $1.1334 | $1.1581 | $1.1326 | -51.77% |
| May, 2027 | $1.0906 | $1.1316 | $1.125 | -53.59% |
| June, 2027 | $1.1335 | $1.1289 | $1.1155 | -51.76% |
| July, 2027 | $1.0787 | $1.0979 | $1.0931 | -54.10% |
| August, 2027 | $1.1058 | $1.0795 | $1.0769 | -52.94% |
| September, 2027 | $2.5741 | $1.1147 | $4.4557 | +9.54% |
| October, 2027 | $3.3509 | $2.4889 | $3.8609 | +42.59% |
| November, 2027 | $2.6378 | $2.5351 | $3.9351 | +12.24% |
| December, 2027 | $1.13 | $0.00 | $2.9235 | -51.91% |
Gt Biopharma Inc Stock (GTBP) Price Forecast for 2028
In 2028, Gt Biopharma Inc (GTBP) is projected to reach an average price of $7.9838, with a high projection of $15.80 and a low estimate of $0.1716. This indicates an +239.74% rise from the last price of $2.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.7136 | $0.1716 | $2.9536 | +15.47% |
| February, 2028 | $5.8273 | $2.412 | $6.8489 | +147.97% |
| March, 2028 | $10.39 | $4.4057 | $13.49 | +342.10% |
| April, 2028 | $14.04 | $10.66 | $15.80 | +497.57% |
| May, 2028 | $8.395 | $8.335 | $13.18 | +257.23% |
| June, 2028 | $6.1486 | $5.7586 | $9.1134 | +161.64% |
| July, 2028 | $4.5522 | $3.027 | $6.087 | +93.71% |
| August, 2028 | $2.8443 | $2.6443 | $5.0807 | +21.03% |
| September, 2028 | $2.6979 | $1.6727 | $3.0895 | +14.80% |
| October, 2028 | $0.7115 | $0.4615 | $3.7363 | -69.72% |
| November, 2028 | $0.0436 | $0.225 | $0.88 | -98.15% |
| December, 2028 | $0.9928 | $0.648 | $0.5928 | -57.75% |
Gt Biopharma Inc Stock (GTBP) Price Forecast for 2029
The 2029 price forecast for Gt Biopharma Inc Stock (GTBP) is $0.9885 on average, with a high prediction of $1.473 and a low estimate of $0.5039. This represents an -57.94% decrease from the previous price of $2.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6807 | $0.906 | $0.5892 | -71.03% |
| February, 2029 | $0.5771 | $0.5039 | $0.3155 | -75.44% |
| March, 2029 | $0.6235 | $0.6935 | $0.5485 | -73.47% |
| April, 2029 | $1.3898 | $1.2051 | $1.1398 | -40.86% |
| May, 2029 | $0.6978 | $0.7878 | $1.473 | -70.31% |
| June, 2029 | $0.4442 | $0.6142 | $0.5694 | -81.10% |
| July, 2029 | $0.9105 | $0.6108 | $0.4405 | -61.25% |
| August, 2029 | $0.6485 | $0.6153 | $0.4585 | -72.40% |
| September, 2029 | $0.7949 | $0.7932 | $0.7117 | -66.18% |
| October, 2029 | $1.4228 | $1.3265 | $1.3596 | -39.45% |
| November, 2029 | $1.2292 | $1.3876 | $1.3644 | -47.69% |
| December, 2029 | $1.5556 | $1.2308 | $1.3756 | -33.81% |
Gt Biopharma Inc Stock (GTBP) Price Forecast for 2030
Gt Biopharma Inc Stock (GTBP) is expected to reach an average price of $2.1778 in 2030, with a high forecast of $2.6785 and a low forecast of $1.6771. This signifies an -7.33% decrease from the last price of $2.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.2778 | $1.6771 | $2.028 | -3.07% |
| February, 2030 | $2.2799 | $2.1967 | $2.1383 | -2.98% |
| March, 2030 | $2.2763 | $2.3147 | $2.2462 | -3.13% |
| April, 2030 | $2.5026 | $2.4458 | $2.3421 | +6.49% |
| May, 2030 | $2.5506 | $2.5508 | $2.429 | +8.54% |
| June, 2030 | $2.7019 | $2.6372 | $2.6569 | +14.98% |
| July, 2030 | $2.5952 | $2.6649 | $2.6785 | +10.43% |
| August, 2030 | $2.6301 | $2.6313 | $2.5917 | +11.92% |
| September, 2030 | $2.6026 | $2.6039 | $2.5936 | +10.75% |
| October, 2030 | $2.5746 | $2.5856 | $2.5822 | +9.56% |
| November, 2030 | $2.5557 | $2.5538 | $2.5332 | +8.75% |
| December, 2030 | $2.5143 | $2.5373 | $2.5286 | +6.99% |
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):